Category Archives: Pharma & Biotech

Pharma & Biotech Press Releases & News distributed via EuropaWire

PLIVA received three Golden Indexes 2016 awards

ZAGREB, 28-Mar-2017 — /EuropaWire/ — At the award ceremony held on 21 March 2017, Golden Indexes 2016 were awarded to companies that contributed greatly to the quality of students’ lives, education and development in 2016. PLIVA received as many as three … Read the full press release

University of Dundee awarded grant from Innovate UK to create an Antibacterial Drug Discovery Accelerator

Dundee, Scotland, 27-Mar-2017 — /EuropaWire/ — Antimicrobial resistance is one of the greatest threats to global human and animal health – the O’Neill Report published last year stated that, unless we take urgent action, it will be directly responsible for over … Read the full press release

Researchers Start New Clinical Trial for the Treatment of Genetic Blindness

OXFORD, 22-Mar-2017 — /EuropaWire/ — Researchers have started a new gene therapy clinical trial to treat X-linked retinitis pigmentosa (XLRP), the most common cause of blindness in young people. Retinitis pigmentosa is currently untreatable and leads to a slow and irreversible … Read the full press release

VAAM Elects Founder and CEO of Organo Balance as New First Vice President

VAAM aims to turn microbiology research into products which benefit society BERLIN, 22-Mar-2017 — /EuropaWire/ — The founder and CEO of Organobalance GmbH, Prof. Dr. Christine Lang, is the new first vice president of the Association for General and Applied Microbiology … Read the full press release

Regulations Called For Data-sharing Arrangements Between NHS and Google DeepMind

A study of a deal which has allowed Google DeepMind access to millions of healthcare records argues that more needs to be done to regulate such agreements between public sector bodies and private technology firms. CAMBRIDG, 20-Mar-2017 — /EuropaWire/ — … Read the full press release

Dundee, Edinburgh embark on joint Regenerative Medicine Research

DUNDEE, 10-Mar-2017 — /EuropaWire/ — Research teams based at the Universities of Dundee and Edinburgh are looking to partner with the pharmaceutical industry to better understand the biological processes that could allow the development of new drugs to support tissue regeneration … Read the full press release

Philips is the world’s largest patent applicant for the second consecutive year

Philips filed 2,568 patent applications* at the EPO during 2016 Company maintains number-one position in three strategic patent filing areas: ‘Medical Technology’, ‘Electrical machinery, apparatus, energy’ and ‘Measurement’  AMSTERDAM, 08-Mar-2017 — /EuropaWire/ — Leading health technology company Royal Philips (NYSE: PHG, … Read the full press release

Philips and LabPON to Create Largest Digital Pathology Database

Best, the Netherlands, 08-Mar-2017 — /EuropaWire/ — Royal Philips (NYSE: PHG, AEX: PHIA) and LabPON, the first clinical laboratory to transition to 100% histopathology digital diagnosis, today announced its plans to create a digital database of massive aggregated sets of annotated … Read the full press release

Hemophilia Awareness Month: Save One Life is dedicated to helping children with hemophilia worldwide

March is Hemophilia Awareness Month and April 17 is International Hemophilia Day LUXEMBOURG, 06-Mar-2017 — /EuropaWire/ — Hemophilia is a devastating inherited blood disorder that can still cause severe pain, crippling and even death, when untreated. Hemophilia patients in developed … Read the full press release

MedImmune and Sanofi Pasteur to jointly develop and commercialise respiratory syncytial virus monoclonal antibody

LONDON, 03-Mar-2017 — /EuropaWire/ — MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur, the vaccines division of Sanofi, today announced an agreement to develop and commercialise MEDI8897 jointly. MEDI8897 is a monoclonal antibody (mAb) for the … Read the full press release

AstraZeneca announce FDA approval of once-daily Qtern for the treatment of type-2 diabetes

Qtern fixed-dose combination will provide an additional oral medicine option for patients taking Farxiga (dapagliflozin) to improve blood sugar level LONDON, 03-Mar-2017 — /EuropaWire/ — AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved once-daily Qtern (10mg … Read the full press release

BBVA Foundation bestows the Frontiers of Knowledge Award to “neglected diseases” fighters

BILBAO, 02-Mar-2017 — /EuropaWire/ — The BBVA Foundation is distinguishing, in this ninth edition of the Frontiers of Knowledge Award, in the Development Cooperation category researchers Pedro Alonso and Peter Myler, for their pivotal role in the fight against infectious diseases … Read the full press release

Nor-Tech Offers European Organizations Free Simulation Tests on a High Performance Computer Cluster for CAE, CFD, FEA Software

Nor-Tech, the top provider of powerful, user-friendly computers, just announced a free simulation test on a high performance computer cluster for CAE,CFD,FEA software MINNEAPOLIS, U.S., 01-Mar-2017 — /EuropaWire/ — Nor-Tech, the top provider of powerful, user-friendly computers, just announced a … Read the full press release

Study Showcases Economic Value of Earlier Patient Access to Medtronic Cardiac Resynchronization Therapy Devices

DUBLIN, 28-Feb-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced an economic analysis of five-year data showing that patients with mild heart failure who get cardiac resynchronization therapy (CRT) devices early in their treatment live longer and that implanting these devices … Read the full press release

Medtronic to present at the 37th Annual Cowen and Company Healthcare Conference on March 7, 2017

DUBLIN, 28-Feb-2017 — /EuropaWire/ — Medtronic plc  (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 37th Annual Cowen and Company Healthcare Conference on Tuesday, March 7, 2017, in Boston, Mass. Geoff Martha, executive vice president … Read the full press release

Medtronic receives CE (Conformité Européenne) Mark for its suite of quadripolar cardiac resynchronization therapy pacemakers

Suite of Smart Heart Failure Devices Offers More-Effective Pacing, Expanded MRI Access DUBLIN, 28-Feb-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced that it has received CE (Conformité Européenne) Mark for a suite of quadripolar cardiac resynchronization therapy pacemakers (CRT-Ps) that … Read the full press release

Bayer Science & Education Foundation awards €30,000 to Basel University Hospital neurologist

Dr. David Seiffge Doctor at Basel University Hospital honored for clinical work on management of non-vitamin K dependent oral anticoagulants in acute stroke patients LEVERKUSEN, 21-Feb-2017 — /EuropaWire/ — The third winner of the Bayer Thrombosis Research Award has been chosen. … Read the full press release

Additional state-of-the-art instruments installed in SGS Fairfield, New Jersey lab; hiring underway for additional analysts

GENEVA, 31-Jan-2017 — /EuropaWire/ — SGS, a leading bio/pharmaceutical, analytical and bioanalytical contract solutions provider, today announced that it has made additional investments at its laboratory in Fairfield, New Jersey, to increase services and capacity in support of extractables and leachables … Read the full press release

Johnson & Johnson to acquire all of the outstanding shares of Actelion for $280 per share payable in U.S. dollars

In the previous press release the companies omitted the cash amount with which R&D NewCo will launch. This has now been rectified and noted as CHF 1 billion. Actelion Shareholders to Receive $280 Per Actelion Share in All-Cash Tender Offer to … Read the full press release

Medtronic presents results supporting the IN.PACT® Admiral® drug-coated balloon in patients with peripheral arterial disease

First Presentation of Results from Regional Cohorts of IN.PACT Global Study Reinforce Strong, Consistent and Safe Outcomes for PAD Patients  DUBLIN and LEIPZIG, 25-Jan-2017 — /EuropaWire/ — Medtronic today presented new data at the Leipzig Interventional Course (LINC) 2017 conference supporting … Read the full press release

Medtronic expands directional atherectomy portfolio in Europe with new 6F HawkOne

Expands Treatment Options for Patients in Europe with Peripheral Artery Disease Both Above and Below the Knee DUBLIN, 25-Jan-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced CE (Conformité Européene) Mark approval for the HawkOne(TM) directional atherectomy system in a … Read the full press release

Medtronic announces first procedure using Visualase(TM) MRI-Guided Laser Ablation System for treatment of common form of epilepsy

DUBLIN, 25-Jan-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) announced today that the first procedure using the Visualase(TM) MRI-Guided Laser Ablation System has been performed in the pivotal SLATE (Stereotactic Laser Ablation for Temporal Lobe Epilepsy) clinical trial at Mayo Clinic … Read the full press release

Shire plc: U.S. FDA acknowledged receipt of the Class 2 resubmission of a New Drug Application (NDA) for SHP465

Lexington, Mass., USA, 20-Jan-2017 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the Class 2 resubmission of a New Drug Application (NDA) for SHP465, a long-acting, triple-bead, … Read the full press release

Novartis collaborates with Ionis and Akcea to license two novel treatments to reduce cardiovascular risk in patients with high levels of lipoproteins

Novartis enters into an exclusive option agreement with Ionis and Akcea to license two investigational treatments expected to significantly reduce cardiovascular risk in patients living with elevated levels of lipoprotein Lp(a) or ApoCIII, which is a potent regulator of triglycerides … Read the full press release

Sanofi’s Soliqua™ 100/33 now available by prescription in U.S. for the treatment of adults with type 2 diabetes

PARIS, 04-Jan-2017 — /EuropaWire/ — Sanofi announced today that Soliqua™ 100/33 (insulin glargine 100 Units/mL & lixisenatide* 33 mcg/mL injection) is now available by prescription in U.S. pharmacies. Soliqua 100/33 is indicated for the treatment of adults with type 2 … Read the full press release

Sanofi’s Merial and Boehringer Ingelheim’s CHC business swap successfully closed

Both companies will become global leaders in two different sectors of the pharmaceutical market Paris (France) and Ingelheim (Germany), 03-Jan-2017 — /EuropaWire/ — Sanofi and Boehringer Ingelheim confirmed today that the strategic transaction signed in June 2016, which consists of an … Read the full press release

Sanofi Pasteur and MSD to separately pursue their own vaccine strategies in Europe

PARIS, 03-Jan-2017 — /EuropaWire/ — Sanofi and its vaccines global business unit Sanofi Pasteur confirmed today the end of their vaccine joint-venture with MSD (known as Merck & Co. Inc., in the United States and Canada), Sanofi Pasteur MSD (SPMSD). … Read the full press release

Research looks into the impact and cost-effectiveness of the Dengvaxia vaccine under a host of varying conditions

Exeter, UK, 01-Dec-2016 — /EuropaWire/ — The first licensed vaccine for the potentially life-threatening dengue virus should only be used in moderate-to high impacted regions, new research has predicted. A team of international researchers, including Dr Mario Recker from the University … Read the full press release

Rwanda becomes the third country to sign a MoU with Novartis Access

Rwanda becomes third country to launch Novartis Access portfolio against chronic diseases with first deliveries planned in early 2017 Since September 2015, Novartis Access has delivered more than 100,000 monthly treatments to Kenya, Ethiopia and Lebanon* First-year learnings underline broader … Read the full press release

Boehringer Ingelheim and China Southeast University Institute of Life Sciences to develop new treatment approaches for hearing loss

360 million people worldwide suffer from disabling hearing loss with no effective treatment available New collaboration with China Southeast University is part of the Research Beyond Borders (RBB) initiative, which aims to explore emerging science within and beyond Boehringer Ingelheim’s … Read the full press release